Skip to main content
Clinical Trials/NCT04886856
NCT04886856
Recruiting
N/A

Mindful Moms Randomized Control Trial Study

Virginia Commonwealth University1 site in 1 country200 target enrollmentOctober 15, 2021
ConditionsDepression

Overview

Phase
N/A
Intervention
Not specified
Conditions
Depression
Sponsor
Virginia Commonwealth University
Enrollment
200
Locations
1
Primary Endpoint
Change in Depressive symptom severity
Status
Recruiting
Last Updated
6 months ago

Overview

Brief Summary

The purpose of this study is to test whether a program called "Mindful Moms" can be helpful for specific measures of mood and health in pregnant women with depressive symptoms, compared to group-based education workshops.

Detailed Description

The Mindful Moms Study is a randomized controlled trial, in which participants will be randomly assigned (like the flip of a coin) to either the "Mindful Moms" group (12 weeks of group-based prenatal yoga) or the "Prenatal Education Circle" group (12 weeks of group-based prenatal education). 200 pregnant women will participate over the course of the study.

Registry
clinicaltrials.gov
Start Date
October 15, 2021
End Date
June 30, 2026
Last Updated
6 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • pregnant woman at 12-26 weeks gestation at baseline visit;
  • defined as minority (e.g., Black/ African American, Hispanic/ Latino, Native American, etc) and/or annual household income at qualification level for Women, Infants, \& Children \[WIC\] benefits in Virginia and/or educational attainment ≤high school education;
  • current depressive symptoms, as defined by a score ≥7 on the Edinburgh Postnatal Depression Scale (EPDS);
  • able to read, write, and understand English;
  • has not been told by a healthcare provider to avoid physical activity;
  • has not engaged in a consistent (once/week or more) yoga-based practice during the current pregnancy.

Exclusion Criteria

  • Does not meet the inclusion criteria above.

Outcomes

Primary Outcomes

Change in Depressive symptom severity

Time Frame: Baseline to postpartum, about 8 months

Depressive symptoms will be assessed using the Edinburgh Postnatal Depression Scale (EPDS). The EDPS is a widely used and validated measure of depressive symptoms, with 10 questions appropriate for the prenatal and postpartum woman; a score ≥10 (range 0-30) suggests possible depressive symptoms.

Secondary Outcomes

  • Change in anxiety(Baseline to postpartum, about 8 months)
  • Change in stress(Baseline to postpartum, about 8 months)

Study Sites (1)

Loading locations...

Similar Trials